Leerink Partners analyst Marc Goodman maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the

How is one of the world’s largest pharmaceutical companies promoting sustainability and regulatory compliance throughout its extensive supply chain?

Jordana Brewster commented on persistent rumors of "drama" between her 'Fast and Furious' costars Vin Diesel and Dwayne Johnson, saying, "Families are also dysfunctional, and we've got the drama and we've got - so I think the franchise echoes that.

As Chicago Bears head coach Ben Johnson fills out his coaching staff, here are 10 candidates to monitor for key roles with the team.

On Thursday evening, the Los Angeles Lakers beat the Boston Celtics (at home) by a score of 117-96. LeBron James and Anthony Davis combined for 44 points, 22 r

Some of the resources Johnson highlighted include phone numbers for anyone "witnessing ICE activity," with recommended steps to take if an "officer knocks on your door at home."

The company reported revenue of $22.5 billion and adjusted earnings of $2.04 per share, compared to the consensus estimates of $22.4 billion and $2.02, respectively.

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray,

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Stifel analyst Rick Wise lowered the firm’s price target on Johnson & Johnson to $155 from $170 and keeps a Hold rating on the shares.